Live Breaking News & Updates on Medleaf Therapeutics
Stay updated with breaking news from Medleaf therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Police confiscate prescribed medicinal cannabis after pulling over driver stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
Police take prescribed medicinal cannabis after pulling over driver stuff.co.nz - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from stuff.co.nz Daily Mail and Mail on Sunday newspapers.
New Zealand is facing a collapse of legal medicinal cannabis supply after March 31, when a deadline to meet stiff new government rules is expected to keep the products of three of the country’s five main importers out of the market, reports NZ Herald’s Kate MacNamara in this Herald Premium article. Last April, the government unveiled a new regulatory system to create more safe, widespread and affordable access to medicinal cannabis. It has not yet approved a single product. New Zealand-based importers Medleaf Therapeutics, Nubu Pharmaceuticals, and Eqalis Pharmaceuticals confirmed their products are not likely to be approved under the new standards before the March deadline. Domestic production, still in its very early stages, is not likely to reach the market until late this year. ....
New Zealand s medicinal cannabis supply in jeopardy 5 Feb, 2021 04:27 AM 6 minutes to read NZ Herald By: Kate MacNamara New Zealand is facing a collapse of legal medicinal cannabis supply after March 31st, when a deadline to meet stiff new government rules is expected to keep the products of three of the country s five main importers out of the market. Last April, the Government unveiled a new regulatory system to create more safe, widespread and affordable access to medicinal cannabis, it has not yet approved a single product. New Zealand-based importers Medleaf Therapeutics, Nubu Pharmaceuticals, and Eqalis Pharmaceuticals confirmed their products are not likely to be approved under the new standards before the March deadline. Domestic production, still in its very early stages, is not likely to reach the market until late this year. ....